INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo DOXOLIP concentrate for infusion

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
no data

PROPRIETARY NAME
(and dosage form):

DOXOLIP concentrate for infusion

COMPOSITION:
Each vial contains
doxorubicin hydrochloride 2,0 mg

ATC CLASSIFICATION:
L01DB01

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
43/26/0018

APPLICANT:
Pharmaplan (Pty) Ltd

MANUFACTURER:
SUN PHARMACEUTICAL INDUSTRIES LTD, DISTRICT PANCMAHAL, GUJARAT, INDIA

AVAILABILITY:
no data - please check with company.

DATE OF REGISTRATION:
05 December 2013

SOURCE: Government Gazette -
STAATSKOERANT, 13 JUNIE 2014 No. 37727
NOTICE 405 OF 2014 - MEDICINES CONTROL COUNCIL

Date posted: July 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014